Humana Inc. [NYSE: HUM] traded at a high on 06/08/20, posting a 2.11 gain after which it closed the day’ session at $398.10. The results of the trading session contributed to over 1258553 shares changing hands. Over the past one week, the price volatility of Humana Inc. stands at 3.95% while the volatility over the past one month is 3.37%.
The market cap for HUM stock reached $52.96 billion, with 132.14 million shares outstanding and 131.88 million shares in the current float. Compared to the average trading volume of 1.49M shares, HUM reached a trading volume of 1258553 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Get 12 free stock market lessons delivered to your email from Investor's Business Daily, the leader in investing education for over 35 years. We’ll cover the basics of better investing and show you how to give yourself an edge in the market.
GET FREE LESSON outside the norm.
What do top market gurus say about Humana Inc. [HUM]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for HUM shares is $427.86 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on HUM stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Goldman have made an estimate for Humana Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on June 05, 2020. While these analysts kept the previous recommendation, JP Morgan raised their target price from $437 to $448. The new note on the price target was released on January 03, 2020, representing the official price target for Humana Inc. stock. Previously, the target price had yet another raise to $316, while Mizuho analysts kept a Buy rating on HUM stock. On September 30, 2019, analysts decreased their price target for HUM shares from 345 to 290.
The Average True Range (ATR) for Humana Inc. is set at 14.27, with the Price to Sales ratio for HUM stock in the period of the last 12 months amounting to 0.78. The Price to Book ratio for the last quarter was 4.26, with the Price to Cash per share for the same quarter was set at 45.51. Price to Free Cash Flow for HUM in the course of the last twelve months was 14.02.
How has HUM stock performed recently?
Humana Inc. [HUM] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -0.85. With this latest performance, HUM shares gained by 7.18% in over the last four-week period, additionally plugging by 15.32% over the last 6 months – not to mention a rise of 59.96% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for HUM stock in for the last two-week period is set at 58.01, with the RSI for the last a single of trading hit 55.15, and the three-weeks RSI is set at 57.24 for Humana Inc. [HUM]. The present Moving Average for the last 50 days of trading for this stock 368.21, while it was recorded at 395.77 for the last single week of trading, and 330.63 for the last 200 days.
Humana Inc. [HUM]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Humana Inc. [HUM] shares currently have an operating margin of +4.92. Humana Inc.’s Net Margin is presently recorded at +4.17.
Return on Total Capital for HUM is now 18.57, given the latest momentum, and Return on Invested Capital for the company is 16.99. Return on Equity for this stock inclined to 24.39, with Return on Assets sitting at 9.85. When it comes to the capital structure of this company, Humana Inc. [HUM] has a Total Debt to Total Equity ratio set at 50.79. Additionally, HUM Total Debt to Total Capital is recorded at 33.68, with Total Debt to Total Assets ending up at 20.86. Long-Term Debt to Equity for the company is recorded at 44.02, with the Long-Term Debt to Total Capital now at 29.19.
Reflecting on the efficiency of the workforce at the company, Humana Inc. [HUM] managed to generate an average of $58,848 per employee.
Earnings analysis for Humana Inc. [HUM]
With the latest financial reports released by the company, Humana Inc. posted 6.05/share EPS, while the average EPS was predicted by analysts to be reported at 5.3/share.When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 14.20%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for HUM. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Humana Inc. go to 12.28%.
Insider trade positions for Humana Inc. [HUM]
There are presently around $48,636 million, or 95.70% of HUM stock, in the hands of institutional investors. The top three institutional holders of HUM stocks are: BLACKROCK INC. with ownership of 10,810,345, which is approximately -10.709% of the company’s market cap and around 0.20% of the total institutional ownership; VANGUARD GROUP INC, holding 10,505,705 shares of the stock with an approximate value of $4.1 billion in HUM stocks shares; and PRICE T ROWE ASSOCIATES INC /MD/, currently with $3.71 billion in HUM stock with ownership of nearly 399.712% of the company’s market capitalization.
353 institutional holders increased their position in Humana Inc. [NYSE:HUM] by around 17,226,860 shares. Additionally, 455 investors decreased positions by around 17,509,402 shares, while 106 investors held positions by with 90,015,253 shares. The mentioned changes placed institutional holdings at 124,751,515 shares, according to the latest SEC report filing. HUM stock had 101 new institutional investments in for a total of 1,948,943 shares, while 117 institutional investors sold positions of 1,418,789 shares during the same period.